These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19339697)

  • 21. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.
    Strobl LJ; Höfelmayr H; Stein C; Marschall G; Brielmeier M; Laux G; Bornkamm GW; Zimber-Strobl U
    Immunobiology; 1997 Dec; 198(1-3):299-306. PubMed ID: 9442401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance.
    Gordadze AV; Poston D; Ling PD
    J Virol; 2002 Jul; 76(14):7349-55. PubMed ID: 12072534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.
    Farrell CJ; Lee JM; Shin EC; Cebrat M; Cole PA; Hayward SD
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4625-30. PubMed ID: 15070768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
    Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE
    PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells.
    Pagès F; Galon J; Karaschuk G; Dudziak D; Camus M; Lazar V; Camilleri-Broët S; Lagorce-Pagès C; Lebel-Binay S; Laux G; Fridman WH; Henglein B
    Blood; 2005 Feb; 105(4):1632-9. PubMed ID: 15498855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
    J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.
    Campion EM; Hakimjavadi R; Loughran ST; Phelan S; Smith SM; D'Souza BN; Tierney RJ; Bell AI; Cahill PA; Walls D
    J Virol; 2014 May; 88(9):5001-13. PubMed ID: 24554662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk.
    Kim JH; Kim WS; Hong JY; Ryu KJ; Kim SJ; Park C
    Oncotarget; 2017 Jan; 8(3):5361-5370. PubMed ID: 28036258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of the J recombination signal sequence binding protein (RBP-J)/Epstein-Barr virus nuclear antigen 2 (EBNA2) and RBP-J/Notch interaction.
    Fuchs KP; Bommer G; Dumont E; Christoph B; Vidal M; Kremmer E; Kempkes B
    Eur J Biochem; 2001 Sep; 268(17):4639-46. PubMed ID: 11532000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis.
    Lee JM; Lee KH; Weidner M; Osborne BA; Hayward SD
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11878-83. PubMed ID: 12195020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.
    Tierney RJ; Kao KY; Nagra JK; Rickinson AB
    J Virol; 2011 Dec; 85(23):12362-75. PubMed ID: 21957300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
    Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
    Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2.
    Sakai T; Taniguchi Y; Tamura K; Minoguchi S; Fukuhara T; Strobl LJ; Zimber-Strobl U; Bornkamm GW; Honjo T
    J Virol; 1998 Jul; 72(7):6034-9. PubMed ID: 9621066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Epstein-Barr virus EBNA2 protein induces a subset of NOTCH target genes in thyroid cancer cell lines but fails to suppress proliferation.
    Golden S; Yu XM; Odorico S; Jain V; Marin A; Ma S; Kenney S; Chen H
    Surgery; 2017 Jan; 161(1):195-201. PubMed ID: 27847111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization.
    Mühe J; Wang F
    PLoS Pathog; 2017 Dec; 13(12):e1006772. PubMed ID: 29261800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
    Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
    J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.
    Kempkes B; Spitkovsky D; Jansen-Dürr P; Ellwart JW; Kremmer E; Delecluse HJ; Rottenberger C; Bornkamm GW; Hammerschmidt W
    EMBO J; 1995 Jan; 14(1):88-96. PubMed ID: 7828599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
    Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
    Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
    Su C; Lu F; Soldan SS; Lamontagne RJ; Tang HY; Napoletani G; Farrell PJ; Tempera I; Kossenkov AV; Lieberman PM
    PLoS Pathog; 2021 Aug; 17(8):e1009834. PubMed ID: 34352044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas.
    Anastasiadou E; Stroopinsky D; Alimperti S; Jiao AL; Pyzer AR; Cippitelli C; Pepe G; Severa M; Rosenblatt J; Etna MP; Rieger S; Kempkes B; Coccia EM; Sui SJH; Chen CS; Uccini S; Avigan D; Faggioni A; Trivedi P; Slack FJ
    Leukemia; 2019 Jan; 33(1):132-147. PubMed ID: 29946193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.